Evaluation of cardiac function in patients with liver cirrhosis

Internal Medicine

Volumn 49, Issue 23, 2010, Pages 2547-2552

  Abd El Aziz, Tarek A ^a   Abdou, Mohamed ^a   Fathy, Ahmed ^b   Wafaie, Mohamed ^a  

^a ZAGAZIG UNIVERSITY   (Egypt)

^b NATIONAL HEART INSTITUTE   (Egypt)

Author keywords

Cardiac function; Echo doppler; Liver cirrhosis

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLE; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; ELECTROCARDIOGRAM; HEART CONTRACTION; HEART EJECTION FRACTION; HEART FUNCTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE HYPERTROPHY; HUMAN; LABORATORY TEST; LIVER CIRRHOSIS; M MODE ECHOCARDIOGRAPHY; QT INTERVAL; SMOOTH MUSCLE RELAXATION; SYSTOLE; SYSTOLIC BLOOD PRESSURE; TISSUE DOPPLER IMAGING; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART FUNCTION TESTS; HEMODYNAMICS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED;

EID: 78649794390     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.3520     Document Type: Article

References (29)

1. Kowalski HJ, Abelmann WH. The cardiac output at rest in Laennec's cirrhosis. J Clin Invest 32: 1025-1033, 1953.
2. Milani A, Zaccaria R, Bombardieri G, Gasbarrini A, Pola P. Cirrhotic cardiomyopathy. Dig Liver Dis 39: 507-515, 2007.
3. Baik SK, Fouad TR, Lee SS. Cirrhotic cardiomyopathy. Orphanet J Rare Dis 27: 2-15, 2007.
4. Haskal ZJ, Rees CR, Ring EJ, Saxon R, Sacks D. Reporting standards for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 14: S419-S426, 2003.
5. Takahara A, Sugiyama A, Hashimoto K. Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation. Br J Pharmacol 146: 561-567, 2005.
6. Pasquet A, Armstrong G, Beachler L, et al. Use of segmental tissue Doppler velocity to quantitate exercise echocardiography. J Am Soc Echocardiogr 12: 901-912, 1999.
7. Meluzin J, Spinarova L, Bakala J, et al. Pulsed Doppler tissue imaging of the velocity of tricuspid annular systolic motion; a new, rapid, and non-invasive method of evaluating right ventricular systolic function. Eur Heart J 22: 340-348, 2001.
8. Nagueh SF, Lakkis NM, Middleton KJ, et al. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation 99: 254-261, 1999.
9. Knapp RG, Miller MC. Describing the performance of a diagnostic test. In: Clinical Epidemiology and Biostatistics. Williams & Wilkins, Baltimore, 1992: 31-45.
10. Ho JK, Youshida E. The extrahepatic consequences of cirrhosis. Med Gen Med 8: 59, 2006.
11. Therapondos G, Flapan AD, Plevris JN, Hayes PC. Cardiac morbidity and mortality related to orthotopic liver transplantation. Liver Transpl 10: 1441-1453, 2004.
12. Baik SK, Fouad TR, Lee SS. Cirrhotic cardiomyopathy. Orphanet J Rare Dis 27: 2-15, 2007.
13. Ma Z, Miyamoto A, Lee SS. Role of altered beta-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats. Gastroenterology 110: 1191-1198, 1996.
14. Trevisani F, Sica G, Mainquà P, et al. Autonomic dysfunction and hyperdynamic circulation in cirrhosis with ascites. Hepatology 30: 1387-1392, 1999.
15. Groszmann RJ, Loureiro-Silva MR, Tsai MH. The biology of portal hypertension. In: The Liver: Biology and Pathobiology. 4th ed. Arias IM, Boyer JL, Chisari FV, Fausto N, Schachter D, Shafritz DA, Eds. Lippincott Williams & Wilkins, Philadelphia, 2001: 680-697.
16. Gines P, Ferna ́ndez-Esperrach G, Arroyo V. Ascites and renal functional abnormalities in cirrhosis: pathogenesis and treatment. Clin Gastroenterol 11: 365-385, 1997.
17. Ward CA, Liu H, Lee SS. Altered cellular calcium regulatory systems in a rat model of cirrhotic cardiomyopathy. Gastroenterology 121: 1209-1218, 2001.
18. Liu H, Song D, Lee SS. Cirrhotic cardiomyopathy. Gastroenterol Clin Biol 26: 842-847, 2002.
19. Braunwald E. Evaluation of the patient; Evaluation of systolic and diastolic function. In: Echocardiography. 8th ed. part III, Volume I. Williams and Wilkins, Lippincott, 2008.
20. Naschitz JE, Slobodin G, Lewis RJ, Zuckerman E, Yeshurun D. Heart diseases affecting the liver and liver diseases affecting the heart. Am Heart J 140: 111-120, 2000.
21. Soyoral Y, Süner A, Ki{dotless}di{dotless}r V, Ari{dotless}türk Z, Balakan O, Deǧertekin H. The effect of viral cirrhosis on cardiac ventricular function. Eur J Gen Med 1: 15-18, 2004.
22. Pellerin D, Sharma R, Elliott P, Veyrat C. Tissue Doppler, strain, and strain rate echocardiography for the assessment of left and right systolic ventricular function. Heart 89: iii9-iii17, 2003.
23. Gruber P, Kennedy P, Stoesser N, Wendon J, Auzinger G. Right ventricular dysfunction in liver failure: a hemodynamic study. Critical Care 12 (Suppl 2): 82, 2008.
24. Wong F, Girgrah N, Graba J, Allidina Y, Liu P, Blendis L. The cardiac response to exercise in cirrhosis. Gut 49: 268-275, 2001.
25. Tei C, Nishimura RA, Seward JB, et al. Noninvasive Dopplerderived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr 10: 169-178, 1997.
26. Poulsen SH, Niellsen JC, Anderson R. The influence of heart rate on Doppler-derived myocardial performance index. J Am Soc Echocardiog 13: 379-384, 2000.
27. Feigenbaum H. Myocardial performance index. In: Echocardiography. 6th ed. Chapter 8. Williams and Wilkins, Lippincott, 2005: 239.
28. Trevisani F, Merli M, Savelli F, et al. QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt. J Hepatol 38: 461-467, 2003.
29. Zoellner H, Hofler M, Beckmann R, et al. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Sci 109: 2571-2580, 1996.